RxDoctor Payments Data

Andrew Chernack

Family Medicine · Poughkeepsie, NYNPI 1972500205

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by GSK at 37.4% of the total. Reporting peaked in 2019 at $929 and has fallen 83.3% since, to $155 in 2023.

$2,094in general payments, 2019–2025

Across 127 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$783
  • AstraZeneca$378
  • Johnson & Johnson$284
  • Mylan Specialty L.p.$91
  • Pfizer$81
  • Kowa Pharmaceuticals America, Inc.$64
  • plus $413 from 14 others

What the payments were for

  • Food & beverage$2,08399%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,094 in reported general payments places this provider in the 75th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York →

Other family medicine in Poughkeepsie

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →